Sinusitis, commonly known as a sinus infection, occurs when the nasal cavities become infected, swollen, and inflamed. While ...

Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it's also an all-too-common affliction, affecting an ...

By analyzing nasal polyp tissue from patients, the research team has identified an unusual group of memory CD8+ T cells that secrete granzyme K—rather than the classic granzyme B—and appear in ...

James Mangold, director of this attractive Bob Dylan waxwork, has been admirably sporting about parodies of musical biopics such as the 2007 romp Walk Hard. He would no more be put off making ...

Findings on endoscopy include nasal polyps, mucopurulent drainage or edema/mucosal obstruction, primarily in the middle meatus (Figures 1 & 2). While anterior rhinoscopy may also identify polyps ...

Methodology: Clinical information was gathered retrospectively from 166 cases of surgically treated CRSwNP as well as 60 cases of chronic rhinosinusitis without nasal polyps (CRSsNP). A comparative ...

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory condition characterized by persistent nasal obstruction, discharge, facial pressure, and olfactory dysfunction. CRSwNP ...

CRSwNP is caused by chronic inflammation of the nasal lining that can cause soft tissue growth, known as nasal polyps, that develop in the sinuses and nasal cavity. Up to 80% of patients with CRSwNP ...

CRSwNP is caused by chronic inflammation of the nasal lining that can cause soft tissue growth, known as nasal polyps, that develop in the sinuses and nasal cavity. Up to 80% of patients with CRSwNP ...

The London-based pharmaceuticals firm said Nucala, also known as mepolizumab, was green lit by the China National Medical Products Administration for the treatment of adults with chronic ...

known as nasal polyps, to develop in the sinuses and nasal cavity. Mepolizumab is already approved in China as an add-on maintenance treatment for adults and adolescents aged 12 years and older ...

Ipatasertib is under clinical development by Genentech USA and currently in Phase I for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase I drugs for Paranasal Sinus And Nasal ...